EUCTR2013-004655-21-ES进行中（未招募）1 期
ew Dosing Systems in Paediatrics.Application to the individualization of the dose of fentanyl in neonatal patients.
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Informed consent signed by parents or legal guardians. 2. Neonatal patients between 0 and 27 days of postnatal age and >= 37 weeks of gestational age admitted to the NICU of Cruces Universitary Hospital. 3. Treatment with iv fentanyl with analgesic or sedatives purposes, or with other indications by facultative prescription. 4. First stage of fentanyl treatment following the sedoanalgesia protocol of the NICU of the Cruces Universitary Hospital.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 60
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Sepsis. 2. Liver failure. 3. Renal replacement therapy. 4 Hypersensitivity to fentanyl or opioids in general. 5. Cranioencephalic trauma, increased of intracranial pressure and/or coma.
研究者
相似试验
进行中（未招募）
不适用
ew Dosing Systems in Paediatrics.Application to the individualization of the dose of fentanyl in patients between 1 month and 16 years of age.Analgesia, sedation.EUCTR2013-004742-41-ESKern Pharma S.L.
进行中（未招募）
不适用
Premedication in paediatric patients: Dose finding study of clonidine administrated as nasal aerosol.EUCTR2008-000714-74-SEInstitution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin
已完成
2 期
A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum MalariaMalaria,FalciparumNCT01992900sigma-tau i.f.r. S.p.A.300
进行中（未招募）
1 期
A PAEDIATRIC PHASE I/II STUDY OF INTERMITTENT DOSING OF THE MEK-1 INHIBITOR SELUMETINIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND INOPERABLE PLEXIFORM NEUROFIBROMA AND/OR PROGRESSIVE OPTIC PATHWAY GLIOMANeurofibromatosis type 1 associated plexiform neurofibromas Neurofibromatosis type 1 associated progressive or relapsed optic pathway gliomaMedDRA version: 20.0 Level: LLT Classification code 10029270 Term: Neurofibromatosis, type 1 (von Recklinghausen's disease) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10065866 Term: Plexiform neurofibroma System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10030935 Term: Optic nerve glioma System Organ Class: 100000004864EUCTR2017-002635-41-GBGreat Ormond Street Hospital38
已完成
不适用
Clinical evaluation of the effects of paediatric dental general anaesthesia and midazolam sedation on cognitive function, anxiety and access to future dental careDental caries requiring multiple extractionsOral HealthCariesISRCTN12026431Scottish Executive Chief Scientist Office (UK)200